Back

VEGF-B cardiac gene therapy with differential expression using the anf-promoter or therapy delay during heart failure development in a pre-clinical model of dilated cardiomyopathy.

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 7 - Genetics and gene therapy Genetics and gene therapy ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Felix Woitek

Heart Center of Leipzig, Leipzig (Germany)

5 More presentations in this session

Presentation thumbnail
MicroRNA profiles in patients with cardiac amyloidosis and dilated cardiomyopathy - A preliminary epigenetic approach
Doctor S. Becker (Stuttgart, DE)
Abstract Slides
Presentation thumbnail
GENomE wide analysis of Sotalol-induced IKr inhibition : lack of common variants with large effect sizes.
Professor J. Hulot (Paris, FR)
Abstract
Presentation thumbnail
BACE1-AS long noncoding RNA and beta-amyloid involvement in ischemic heart failure patients
Doctor S. Greco (San Donato Milanese, IT)
Abstract
Presentation thumbnail
MicroRNA 18a is a novel regulator of reverse cholesterol transport and potential therapeutic targets in atherosclerosis
Assistant Professor T. Kim (Seoul, KR)
Abstract Slides
Presentation thumbnail
Brown adipose tissue dysfunction has a pathological role for the progression of cardiac metabolic remodeling in heart failure
Doctor Y. Yoshida (Tokyo, JP)
Abstract

Access the full session

Session thumbnail
Poster session 7 - Genetics and gene therapy

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources